SCHEMBL23770859

SCHEMBL23770859

Cc1ccccc1-c1nc(NSc2cccc(N3CCN(C)CC3)n2)ccc1C(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 6/20 0.44
CYP3A4 P08684 4/20 0.44
CYP2D6 P10635 4/20 0.44
CYP2C19 P33261 3/20 0.44
ALDH1A1 P00352 2/20 0.44
HSD17B10 Q99714 2/20 0.44
KDM4E B2RXH2 1/20 0.44
TSHR P16473 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
HTR3E A5X5Y0 3/20 0.39
HTR3B O95264 3/20 0.39
HTR3A P46098 3/20 0.39
HTR3D Q70Z44 3/20 0.39
HTR3C Q8WXA8 3/20 0.39
TACR1 P25103 6/20 0.39
MAPK1 P28482 1/20 0.36
CNR2 P34972 1/20 0.36
HRH4 Q9H3N8 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23770433 0.92 PDE10A (0.36) CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL23770664 0.91 NPY5R (0.36) CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL23770653 0.90 CNR2 (0.40) CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL23770663 0.90 CYP1A2 (0.43) CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL23770466 0.89 CYP1A2 (0.37) CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL23770647 0.89 KDM4E (0.33) CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL23770840 0.89 KDM4E (0.35) CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL23770723 0.88 PTPN11 (0.35) CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL23770725 0.88 CYP1A2 (0.37) CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL23770753 0.86 GRIN2B (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3504194-B1 N-(PYRIDIN-2-YL)PYRIDINE-SULFONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE NOVARTIS AG (CH) 2021-08-18 EP disclosed